🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fluticasone furoate 50 mcg (4 inhalations)

Found 27 matching trials

Changes in the Lung Clearance Index in Pediatric Patients With Asthma

The multiple breath washout (MBW) is one of pulmonary function test that di...

Status

Unknown

Location

Hospital Infantil de Mexico Federico Gomez

Start Date

2016-03

Trial ID

NCT02678949

Treatments Being Tested

Inhaled Fluticasone 50 mcg/twice day Inhaled Fluticasone 100 mcg/twice day Inhaled Albuterol

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

PHASE2

This is a randomized, placebo-controlled, 2-period crossover, escalating re...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-02-09

Trial ID

NCT02991859

Treatments Being Tested

Fluticasone furoate (FF) Dry Powder Inhaler Fluticasone propionate (FP) Dry Powder Inhaler Budesonide (BUD) Turbuhaler Placebo (ELLIPTA or DISKUS)

Fall Epidemic Viral Pediatric Study

PHASE4

Study ADA113872 is an exploratory 16-week multi-centre, randomized, double-...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-08

Trial ID

NCT01192178

Treatments Being Tested

FLOVENT™ DISKUS™ 100 mcg BID ADVAIR™ DISKUS™ 100/50 mcg BID

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

PHASE2

The primary objective of this study is to evaluate the dose response, effic...

Status

Completed

Location

Teva Investigational Site 10453

Start Date

2013-01

Trial ID

NCT01772368

Treatments Being Tested

Fp MDPI FS MDPI Advair Diskus Albuterol

Relovair PD PK in Chinese Healthy Subjects

PHASE1

In this study, fluticasone furoate (FF) and vilanterol (VI) in different do...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-12-05

Trial ID

NCT01711463

Treatments Being Tested

Fluticasone Furoate/Vilanterol Placebo

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

PHASE3

This purpose of this study is to determine the efficacy and safety of a gra...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00562159

Treatments Being Tested

Placebo SCH 697243 Loratadine 10 mg Rescue Treatment Olopatadine 0.1% Rescue Treatment Mometasone 50 mcg Rescue Treatment Prednisone 5 mg Rescue Treatment Albuterol sulfate 108 mcg Fluticasone propionate 44 mcg Prednisone 5 mg

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

PHASE1

The purpose of this study is to demonstrate dose proportionality of the FF ...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-08-15

Trial ID

NCT01669070

Treatments Being Tested

FF, 50 mcg FF, 100 mcg FF, 200 mcg FF, 250 mcg

Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics

The purpose of this study is to determine whether patients with asthma who ...

Status

Completed

Location

Maternal and Child Health Sciences, Ninewells Hospital and Medical School

Start Date

2007-08

Trial ID

NCT00655616

Treatments Being Tested

Montelukast Placebo Salmeterol, Montelukast

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

PHASE3

The purpose of the study is to investigate the efficacy and safety of a gra...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00550550

Treatments Being Tested

Placebo SCH 697243 Loratadine Syrup 1 mg/mL Rescue Treatment Loratadine 10 mg Rescue Treatment Olopatadine 0.1% Rescue Treatment Mometasone furoate 50 mcg Rescue Treatment Albuterol 108 mcg Rescue Treatment Fluticasone 44 mcg Rescue Treatment Prednisone 5 mg Rescue Treatment

Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year

PHASE4

There is a regulatory requirement to evaluate the extent of reduction (if a...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-07-10

Trial ID

NCT02889809

Treatments Being Tested

Fluticasone furoate Placebo Montelukast Short Acting Beta 2 Agonist

Previous Next